The Circadian Rhythm Sleep Treatment Market to see digitization galore between 2022-2026, reaching USD 857.8 Mn

New York, United States, 2022-Jun-06 — /EPR Network/ —

Persistence Market Research (PMR), a well-known name in market research, has recently released a report that states that the Circadian Rhythm Sleep Treatment Market will witness steadiness at a CAGR of 4.7% and will reach USD 857.8 Million by 2026. The increased number of sleep disorders is likely to boost the growth of the global circadian rhythm sleep disorder market.

According to the Centers for Disease Control and Prevention (CDC), roughly 49.2 million people globally experienced sleeping difficulties in 2017. and this number is increasing with time. Rising awareness regarding sleep problems, as well as technology advancements, are expected to contribute to global market growth.

The North American circadian rhythm sleep disorders market dominates the global circadian rhythm sleep disorders market. This is mostly because of the increasing incidence of sleep disorders, particularly in the United States, which provides significant growth potential for the circadian rhythm sleep disorders market.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/27310

Similarly, increased initiatives to raise awareness about circadian rhythm sleep disorders, increasing disposable income, and a rise in the healthcare budget are among the key factors driving market growth in the Asia-Pacific region.

Company Profiles:

• Vanda Pharmaceuticals Inc.
• Natus Medical Incorporated
• Compumedics Ltd.
• Teva Pharmaceutical Industries Ltd
• Takeda Pharmaceutical Company
• Koninklijke Philips N.V
• Mylan N.V
• Fitbit, Inc
• Garmin Ltd
• Lucimed S.A.
• RedMed Inc.
• Compass Health Brands (Carex Health)
• Beurer GmbH
• Samarit Medical AG
• Lanaform N.V.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/27310

Want More Insights?

PMR has presented a comprehensive report based on Circadian Rhythm Sleep Treatment Market as per Treatment Type (therapeutic devices, drugs and Chronotherapy), Disorder (Delayed Sleep Phase Syndrome (DSPS), Advanced Sleep Phase Syndrome (ASPS), Non–24-h sleep-wake syndrome (Non 24), Irregular Sleep-Wake Disorder (ISWD), Shift Work Disorder and Jet Lag), Distribution Channel (Institutional Sales and Retail Sales) based on seven regions.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/27310

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com